Impact of rapid molecular testing on diagnosis, treatment and management of community-acquired pneumonia in Norway: a pragmatic randomised controlled trial (CAPNOR)

Impact of rapid molecular testing on diagnosis, treatment and management of community-acquired pneumonia in Norway: a pragmatic randomised controlled trial (CAPNOR)

Abstract Background Community-acquired pneumonia (CAP) causes a large burden of disease. Due to difficulties in obtaining representative respiratory samples and insensitive standard microbiological methods, the microbiological aetiology of CAP is difficult to ascertain. With a few exceptions, standa...

Full description

Bibliographic Details
Main Authors: Sondre Serigstad, Christian Ritz, Daniel Faurholt-Jepsen, Dagfinn Markussen, Marit H. Ebbesen, Øyvind Kommedal, Rune O. Bjørneklett, Lars Heggelund, Tristan W. Clark, Cornelis H. van Werkhoven, Siri T. Knoop, Elling Ulvestad, Harleen M. S. Grewal, The CAPNOR study group
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Trials
Subjects:
Community-acquired pneumonia
Respiratory tract infections
Microbiological testing
Rapid diagnostics
FilmArray Pneumonia Panel
Syndromic PCR panel
Online Access:https://doi.org/10.1186/s13063-022-06467-7

Internet

https://doi.org/10.1186/s13063-022-06467-7

Similar Items